Cargando…
Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients
OBJECTIVE: Blau syndrome (BS), a rare, autosomal-dominant autoinflammatory syndrome, is characterized by a clinical triad of granulomatous recurrent uveitis, dermatitis, and symmetric arthritis and associated with mutations of the nucleotide-binding oligomerization domain containing 2 (NOD2) gene. A...
Autores principales: | Zhang, Song, Cai, Zhe, Mo, Xiaolan, Zeng, Huasong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594202/ https://www.ncbi.nlm.nih.gov/pubmed/34781959 http://dx.doi.org/10.1186/s12969-021-00634-x |
Ejemplares similares
-
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review
por: Álvarez-Reguera, Carmen, et al.
Publicado: (2022) -
A Case of Blau Syndrome
por: Chauhan, Krati, et al.
Publicado: (2014) -
Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome
por: Ueki, Yoko, et al.
Publicado: (2023) -
Successful Treatment of Paediatric Morphea with Tofacitinib
por: TANG, Jun-Chi, et al.
Publicado: (2023) -
Blau syndrome with persistent fetal vasculature: a case report
por: Liu, Miao, et al.
Publicado: (2023)